investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targeting monocarboxylate transporter 4 (MCT4) for treatment of castration resistant prostate cancer (CRPC)
Stephen Choi
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Stephen Choi
BC Cancer Agency
Vancouver, Canada
Related projects
Radoslav Goldman
Basic Cancer Research in Cancer Health Disparities
Prostate
Pathology
Philip Tofilon
Radiation-induced translational control of gene expression
Prostate
Radiation Oncology
Tony R Hunter
Signal Transduction by Tyrosine Phosphorylation
Prostate
Joshi J Alumkal
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
Prostate
Pathology
William Figg
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer
Prostate
Pathology
Peter Blumberg
Molecular Mechanism of Action of Phorbol Ester
Prostate
Martin Gleave
Targeting SEMA3C in Castration Resistant Prostate Cancer
Prostate
Pathology
Madonna Peter
Discovery of novel methylation biomarkers in circulating DNA of metastatic castration resistant prostate cancer patients to improve treatment decisions
Prostate
Pathology
Mathieu Lupien
Breast and Prostate Cancer Risk SNPs Regulate FoxA1 and Nuclear Receptor Activity
Prostate